Pricing Log in Create free account
Friday 6 November 2026 Export CORT’s income statement to Excel — free account

Corcept Therapeutics Incorporated

CORT Healthcare Biotechnology

Corcept Therapeutics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $761.4 million, up 12.8% from fiscal 2024.

Revenue
+64.0%
EPS
+525.8%
Free cash flow
+161.0%

Quarter to September 2026, against a year earlier

72.87 1.24 +1.73%
Market cap
$7.8B
P/E
47.5×
Fwd P/E
39.8×
Dividend yield
—
F-score
4/9
Altman Z
14.11
Beneish M
−2.76
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Valuation Filings

Corcept Therapeutics Incorporated (CORT) Book value per share

Alert me on Book value per share

Corcept Therapeutics Incorporated's book value per share at the end of fiscal 2025 was 6.2×, down 5.25% from 6.6× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 7.8×. Over the past ten years it has ranged from 0.2× (fiscal 2015) to 6.6× (fiscal 2024); the current reading is higher than 91% of that period. Corcept Therapeutics Incorporated ranks 99th of 611 Biotechnology companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 6.2× (5.25%)
FY2024 6.6× 34.54%
FY2023 4.9× 4.12%
FY2022 4.7× 44.63%
FY2021 3.2× (28.34%)
FY2020 4.5× 39.70%
FY2019 3.2× 35.71%
FY2018 2.4× 42.19%
FY2017 1.7× 349.52%
FY2016 0.4× 116.18%

Quarterly newest first

Period Book value per share Change
Sep 2026 7.8× 16.74%
Jun 2026 6.7× 9.64%
Mar 2026 6.1× (2.06%)
Dec 2025 6.2× 2.20%
43 more quarters

Against its own ten years

Low 0.2× High 6.6×
Ten-year median 3.2×
Current reading's percentile 91

Book value per share against peers

Company Book value per share
KRYS Krystal Biotech, Inc. compare 48.5×
PRAX Praxis Precision Medicines, Inc. compare 46.0×
MDGL Madrigal Pharmaceuticals, Inc. compare 21.4×
PTGX Protagonist Therapeutics, Inc. compare 12.8×
SYRE Spyre Therapeutics, Inc. compare 11.9×
CORT Corcept Therapeutics Incorporated 7.8×
ABVX Abivax SA Sponsored ADR compare 5.3×
ARWR Arrowhead Pharmaceuticals, Inc. compare 3.3×
CYTK Cytokinetics, Incorporated compare 0.0×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on CORT